Cargando…

Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania

BACKGROUND: Identifying new approaches to tuberculosis treatment that are effective and put less demand to meagre health resources is important. One such approach is community based direct observed treatment (DOT). The purpose of the study was to determine the cost and cost effectiveness of health f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wandwalo, Eliud, Robberstad, Bjarne, Morkve, Odd
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180840/
https://www.ncbi.nlm.nih.gov/pubmed/16018806
http://dx.doi.org/10.1186/1478-7547-3-6
_version_ 1782124620626788352
author Wandwalo, Eliud
Robberstad, Bjarne
Morkve, Odd
author_facet Wandwalo, Eliud
Robberstad, Bjarne
Morkve, Odd
author_sort Wandwalo, Eliud
collection PubMed
description BACKGROUND: Identifying new approaches to tuberculosis treatment that are effective and put less demand to meagre health resources is important. One such approach is community based direct observed treatment (DOT). The purpose of the study was to determine the cost and cost effectiveness of health facility and community based directly observed treatment of tuberculosis in an urban setting in Tanzania. METHODS: Two alternative strategies were compared: health facility based directly observed treatment by health personnel and community based directly observed treatment by treatment supervisors. Costs were analysed from the perspective of health services, patients and community in the year 2002 in US $ using standard methods. Treatment outcomes were obtained from a randomised-controlled trial which was conducted alongside the cost study. Smear positive, smear negative and extra-pulmonary TB patients were included. Cost-effectiveness was calculated as the cost per patient successfully treated. RESULTS: The total cost of treating a patient with conventional health facility based DOT and community based DOT were $ 145 and $ 94 respectively. Community based DOT reduced cost by 35%. Cost fell by 27% for health services and 72% for patients. When smear positive and smear negative patients were considered separately, community DOT was associated with 45% and 19% reduction of the costs respectively. Patients used about $ 43 to follow their medication to health facility which is equivalent to their monthly income. Indirect costs were as important as direct costs, contributing to about 49% of the total patient's cost. The main reason for reduced cost was fewer number of visits to the TB clinic. Community based DOT was more cost-effective at $ 128 per patient successfully treated compared to $ 203 for a patient successfully treated with health facility based DOT. CONCLUSION: Community based DOT presents an economically attractive option to complement health facility based DOT. This is particularly important in settings where TB clinics are working beyond capacity under limited resources.
format Text
id pubmed-1180840
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11808402005-07-28 Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania Wandwalo, Eliud Robberstad, Bjarne Morkve, Odd Cost Eff Resour Alloc Research BACKGROUND: Identifying new approaches to tuberculosis treatment that are effective and put less demand to meagre health resources is important. One such approach is community based direct observed treatment (DOT). The purpose of the study was to determine the cost and cost effectiveness of health facility and community based directly observed treatment of tuberculosis in an urban setting in Tanzania. METHODS: Two alternative strategies were compared: health facility based directly observed treatment by health personnel and community based directly observed treatment by treatment supervisors. Costs were analysed from the perspective of health services, patients and community in the year 2002 in US $ using standard methods. Treatment outcomes were obtained from a randomised-controlled trial which was conducted alongside the cost study. Smear positive, smear negative and extra-pulmonary TB patients were included. Cost-effectiveness was calculated as the cost per patient successfully treated. RESULTS: The total cost of treating a patient with conventional health facility based DOT and community based DOT were $ 145 and $ 94 respectively. Community based DOT reduced cost by 35%. Cost fell by 27% for health services and 72% for patients. When smear positive and smear negative patients were considered separately, community DOT was associated with 45% and 19% reduction of the costs respectively. Patients used about $ 43 to follow their medication to health facility which is equivalent to their monthly income. Indirect costs were as important as direct costs, contributing to about 49% of the total patient's cost. The main reason for reduced cost was fewer number of visits to the TB clinic. Community based DOT was more cost-effective at $ 128 per patient successfully treated compared to $ 203 for a patient successfully treated with health facility based DOT. CONCLUSION: Community based DOT presents an economically attractive option to complement health facility based DOT. This is particularly important in settings where TB clinics are working beyond capacity under limited resources. BioMed Central 2005-07-14 /pmc/articles/PMC1180840/ /pubmed/16018806 http://dx.doi.org/10.1186/1478-7547-3-6 Text en Copyright © 2005 Wandwalo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wandwalo, Eliud
Robberstad, Bjarne
Morkve, Odd
Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
title Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
title_full Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
title_fullStr Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
title_full_unstemmed Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
title_short Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
title_sort cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in dar es salaam, tanzania
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180840/
https://www.ncbi.nlm.nih.gov/pubmed/16018806
http://dx.doi.org/10.1186/1478-7547-3-6
work_keys_str_mv AT wandwaloeliud costandcosteffectivenessofcommunitybasedandhealthfacilitybaseddirectlyobservedtreatmentoftuberculosisindaressalaamtanzania
AT robberstadbjarne costandcosteffectivenessofcommunitybasedandhealthfacilitybaseddirectlyobservedtreatmentoftuberculosisindaressalaamtanzania
AT morkveodd costandcosteffectivenessofcommunitybasedandhealthfacilitybaseddirectlyobservedtreatmentoftuberculosisindaressalaamtanzania